Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study

Stewart J Tepper, Messoud Ashina, Uwe Reuter, Jan Lewis Brandes, David Doležil, Stephen D Silberstein, Paul Winner, Feng Zhang, Sunfa Cheng, Daniel D Mikol